Riyadh, Aug. 21 (BNA): The Saudi Food and Drug Authority (SFDA) signed a memorandum of understanding (MoU) with the Association for the Advancement of Medical Instrumentation (AAMI), aiming to strengthen cooperation between the two organisations in medical devices and focusing on advanced technologies such as artificial intelligence and biotechnology for diagnosis and treatment.

The MoU outlines several areas of cooperation, including the development of medical device standards and related activities, the exchange of technical and scientific information, and the provision of expert consultations. The two sides will also coordinate educational programmes, joint events, and participation in international technical committees.

As a recognised global leader in developing national and international consensus standards on medical device standards and a trusted source for scientific information and training, AAMI applies global best practices to advance the medical device industry, according to the Saudi Press Agency (SPA).

The partnership aligns with SFDA's commitment to collaborating with international organisations to develop policies and build technical capabilities, supporting the goals of the Health Sector Transformation Programme, a key initiative of Saudi Vision 2030.

H.K, S.H.A